Novavax, Inc. has grown revenue −24% a year over three years and −8.3% a year over five. Revenue growth, 3-year annual rate: −24% (Biotechnology median +21%). Revenue growth, 5-year rate: −8.3%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

NVAXNovavax, Inc.

HealthcareUSD

$9.22

$6.2252 weeks$11.19

Is it growing?

Is NVAX growing?

Novavax, Inc. has grown revenue −24% a year over three years and −8.3% a year over five.

−24%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −8.3%
Revenue growth, 5-year rate · −24% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›